Management of Women with Recurrent Pregnancy Losses and Antiphospholipid Antibody Syndrome
Authors:
- 25 March 2013
- journal article
- review article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 69 (6) , 596-607
Abstract
Antiphospholipid antibodies (aPL) have been associated with recurrent pregnancy losses (RPL) and other obstetrical complications. The diagnostic criteria for the classical antiphospholipid antibody syndrome (APS) have been utilized for the detection of obstetrical APS in women with RPL. However, laboratory findings and immunopathology of obstetrical APS are significantly different from those of classical APS. In addition, many women with RPL who have positive aPL do not have symptoms consistent with the current APS criteria. The induction of a proinflammatory immune response from trophoblasts and complement activation by aPL rather than thromboembolic changes has been reported as a major immunopathological feature of obstetrical APS. Heparin treatment has been reported to be effective in prevention of early pregnancy loss with APS but not for the late pregnancy loss or complications. The complex effects of heparin may explain the limited efficacy of heparin treatment in RPL. New diagnostic criteria for obstetrical APS are needed urgently, and new therapeutic approaches should be explored further.Keywords
This publication has 105 references indexed in Scilit:
- Aspirin and Heparin Effect on Basal and Antiphospholipid Antibody Modulation of Trophoblast FunctionObstetrics & Gynecology, 2011
- High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndromeActa Obstetricia et Gynecologica Scandinavica, 2011
- Classical complement activation as a footprint for murine and human antiphospholipid antibody‐induced fetal lossThe Journal of Pathology, 2011
- ORIGINAL ARTICLE: Antiphospholipid Antibodies Induce a Pro‐Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 PathwayAmerican Journal of Reproductive Immunology, 2009
- Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory moleculeLupus, 2008
- Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody–induced fetal injuryBlood, 2007
- Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restrictionJournal of Experimental Medicine, 2006
- Antibodies to anionic phospholipids and anti-β2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosusHuman Immunology, 2003
- Elevated Peripheral Blood Natural Killer Cells Are Effectively Downregulated by Immunoglobulin G Infusion in Women With Recurrent Spontaneous AbortionsAmerican Journal of Reproductive Immunology, 1996
- Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985